Caprock Group, Inc. Danaher Corp Transaction History

Caprock Group, Inc.

  • $4.08 Billion
  • Q3 2025

A detailed history of Caprock Group, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Caprock Group, Inc. holds 12,037 shares of DHR stock, worth $2.66 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,037
Previous 12,781 5.82%
Holding current value
$2.66 Million
Previous $2.62 Million 8.93%
% of portfolio
0.06%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025
SELL
$181.46 - $212.2 $135,006 - $157,876
-744 Reduced 5.82%
12,037 $2.39 Million
Q1 2025

May 15, 2025
SELL
$201.62 - $250.59 $490,541 - $609,685
-2,433 Reduced 15.99%
12,781 $2.62 Million
Q4 2024

Jan 23, 2025
BUY
$226.16 - $274.52 $3.44 Million - $4.18 Million
15,214 New
15,214 $3.49 Million
Q1 2024

Apr 29, 2024
BUY
$224.58 - $256.19 $97,018 - $110,674
432 Added 5.31%
8,564 $2.14 Million
Q4 2023

Jan 18, 2024
SELL
$185.1 - $233.13 $1,295 - $1,631
-7 Reduced 0.09%
8,132 $1.88 Million
Q3 2023

Oct 18, 2023
SELL
$233.08 - $265.59 $98,825 - $112,610
-424 Reduced 4.95%
8,139 $2.02 Million
Q2 2023

Aug 10, 2023
SELL
$224.99 - $256.14 $48,372 - $55,070
-215 Reduced 2.45%
8,563 $2.06 Million
Q1 2023

Apr 26, 2023
BUY
$239.75 - $277.0 $302,564 - $349,574
1,262 Added 16.79%
8,778 $2.21 Million
Q4 2022

Jan 23, 2023
SELL
$241.42 - $282.29 $314,570 - $367,823
-1,303 Reduced 14.77%
7,516 $0
Q3 2022

Nov 07, 2022
BUY
$247.06 - $1507.4 $165,036 - $1.01 Million
668 Added 8.2%
8,819 $2.28 Million
Q2 2022

Jul 26, 2022
BUY
$237.11 - $299.66 $61,648 - $77,911
260 Added 3.29%
8,151 $2.07 Million
Q1 2022

Apr 12, 2022
BUY
$257.27 - $315.76 $76,151 - $93,464
296 Added 3.9%
7,891 $2.32 Million
Q4 2021

Jan 18, 2022
BUY
$292.08 - $329.01 $267,837 - $301,702
917 Added 13.73%
7,595 $2.5 Million
Q3 2021

Oct 07, 2021
BUY
$272.21 - $332.43 $170,403 - $208,101
626 Added 10.34%
6,678 $2.03 Million
Q2 2021

Aug 13, 2021
SELL
$225.08 - $271.69 $51,993 - $62,760
-231 Reduced 3.68%
6,052 $1.63 Million
Q1 2021

Apr 29, 2021
SELL
$212.38 - $245.9 $134,648 - $155,900
-634 Reduced 9.17%
6,283 $1.42 Million
Q4 2020

Jan 29, 2021
SELL
$212.5 - $245.46 $31,025 - $35,837
-146 Reduced 2.07%
6,917 $1.54 Million
Q3 2020

Oct 29, 2020
BUY
$177.16 - $215.33 $58,462 - $71,058
330 Added 4.9%
7,063 $1.52 Million
Q2 2020

Aug 05, 2020
BUY
$128.7 - $176.83 $290,990 - $399,812
2,261 Added 50.56%
6,733 $1.19 Million
Q1 2020

Apr 28, 2020
BUY
$121.39 - $169.05 $13,474 - $18,764
111 Added 2.55%
4,472 $620,000
Q4 2019

Feb 04, 2020
BUY
$133.47 - $153.48 $76,077 - $87,483
570 Added 15.04%
4,361 $670,000
Q3 2019

Oct 31, 2019
BUY
$135.4 - $146.47 $15,164 - $16,404
112 Added 3.04%
3,791 $548,000
Q2 2019

Jul 23, 2019
SELL
$124.88 - $143.73 $345,667 - $397,844
-2,768 Reduced 42.93%
3,679 $526,000
Q1 2019

Apr 12, 2019
BUY
$97.62 - $132.29 $148,675 - $201,477
1,523 Added 30.93%
6,447 $852,000
Q4 2018

Jan 29, 2019
BUY
$94.85 - $109.54 $18,590 - $21,469
196 Added 4.15%
4,924 $509,000
Q3 2018

Oct 17, 2018
SELL
$98.13 - $108.9 $15,406 - $17,097
-157 Reduced 3.21%
4,728 $515,000
Q2 2018

Jul 23, 2018
SELL
$96.1 - $103.24 $42,284 - $45,425
-440 Reduced 8.26%
4,885 $483,000
Q1 2018

Apr 23, 2018
SELL
$92.16 - $103.8 $1,382 - $1,557
-15 Reduced 0.28%
5,325 $522,000
Q4 2017

Jan 17, 2018
SELL
$85.26 - $94.62 $5,456 - $6,055
-64 Reduced 1.18%
5,340 $531,000
Q3 2017

Oct 23, 2017
BUY
$79.29 - $88.45 $428,483 - $477,983
5,404
5,404 $464,000

Others Institutions Holding DHR

# of Institutions
2,478
Shares Held
577M
Call Options Held
5.95M
Put Options Held
3.52M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $161B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email